1. Home
  2. ADAG vs NRDY Comparison

ADAG vs NRDY Comparison

Compare ADAG & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.83

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.83

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
NRDY
Founded
2011
2007
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
254.4M
114.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ADAG
NRDY
Price
$3.83
$0.83
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$8.25
$1.00
AVG Volume (30 Days)
105.7K
401.9K
Earning Date
04-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.88
Revenue Next Year
N/A
$10.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$0.75
52 Week High
$4.75
$1.90

Technical Indicators

Market Signals
Indicator
ADAG
NRDY
Relative Strength Index (RSI) 57.04 46.66
Support Level $3.31 $0.77
Resistance Level $3.99 $0.97
Average True Range (ATR) 0.31 0.05
MACD 0.03 -0.00
Stochastic Oscillator 90.24 39.08

Price Performance

Historical Comparison
ADAG
NRDY

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

Share on Social Networks: